(Stroke. 1999;30:624-629.)
© 1999 American Heart Association, Inc.
Original Contributions |
Thrombolysis With Tissue Plasminogen Activator Alters Adhesion Molecule Expression in the Ischemic Rat Brain
From the Department of Neurology, Henry Ford Health Sciences Center, Detroit (R.L.Z., Z.G.Z., M.C.), and the Department of Physics, Oakland University, Rochester (M.C.), Mich.
Correspondence to Michael Chopp, PhD, Neurology Department, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202. E-mail chopp{at}neuro.hfh.edu
Background and Purpose—We tested the hypothesis that treatment of embolic stroke with recombinant human tissue plasminogen activator (rhtPA) alters cerebral expression of adhesion molecules.
Methods—Male Wistar rats were subjected to middle cerebral artery occlusion by a single fibrin-rich clot. P-selectin, E-selectin, and intercellular adhesion molecule-1 (ICAM-1) immunoreactivity was measured at 6 or 24 hours after embolic stroke in control rats and in rats treated with rhtPA at 1 or 4 hours after stroke. To examine the therapeutic efficacy of combined rhtPA and anti–ICAM-1 antibody treatment at 4 hours after embolization, ischemic lesion volumes were measured in rats treated with rhtPA alone, rats treated with rhtPA and anti–ICAM-1 antibody, and nontreated rats.
Results—Administration of rhtPA at 1 hour after embolization resulted in a significant reduction of adhesion molecule vascular immunoreactivity after embolization in the ipsilateral hemisphere compared with corresponding control rats. However, when rhtPA was administered to rats at 4 hours after embolization, significant increases of adhesion molecule immunoreactivity in the ipsilateral hemisphere were detected. A significant increase of ICAM-1 immunoreactivity was also detected in the contralateral hemisphere at 24 hours after ischemia. A significant reduction in lesion volume was found in rats treated with the combination of rhtPA and anti–ICAM-1 antibody compared with rats treated only with rhtPA.
Conclusions—The present study suggests that the time of initiation of thrombolytic therapy alters vascular immunoreactivity of inflammatory adhesion molecules in the ischemic brain and that therapeutic benefit can be obtained by combining rhtPA and anti–ICAM-1 antibody treatment 4 hours after stroke.
Editorial Comment
Department of Neurosciences, University of California at San Diego, La Jolla, California
This article has been cited by other articles:
 |
|
 |
|
  R. L. Zhang, C. Zhang, L. Zhang, C. Roberts, M. Lu, A. Kapke, Y. Cui, M. Ninomiya, T. Nagafuji, B. Albala, et al. Synergistic Effect of an Endothelin Type A Receptor Antagonist, S-0139, With rtPA on the Neuroprotection After Embolic Stroke Stroke, October 1, 2008; 39(10): 2830 - 2836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. An, C. Zhang, R. Polavarapu, X. Zhang, X. Zhang, and M. Yepes Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein induce Akt phosphorylation in the ischemic brain Blood, October 1, 2008; 112(7): 2787 - 2794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J.T.H. Roelofs, K. M.A. Rouschop, J. C. Leemans, N. Claessen, A. M. de Boer, W. M. Frederiks, H.R. Lijnen, J. J. Weening, and S. Florquin Tissue-Type Plasminogen Activator Modulates Inflammatory Responses and Renal Function in Ischemia Reperfusion Injury J. Am. Soc. Nephrol., January 1, 2006; 17(1): 131 - 140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Zhang, Z. G. Zhang, G. L. Ding, Q. Jiang, X. Liu, H. Meng, A. Hozeska, C. Zhang, L. Li, D. Morris, et al. Multitargeted Effects of Statin-Enhanced Thrombolytic Therapy for Stroke With Recombinant Human Tissue-Type Plasminogen Activator in the Rat Circulation, November 29, 2005; 112(22): 3486 - 3494. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Sughrue, E. S. Connolly Jr, M. Krams, K. R. Lees, W. Hacke, A. P. Grieve, J.-M. Orgogozo, and G. A. Ford Effectively Bridging the Preclinical/Clinical Gap: The Results of the ASTIN Trial * Response Stroke, April 1, 2004; 35(4): e81 - e82. [Full Text] [PDF]
|
|
|
|
|
|
R. Vemuganti, R. J. Dempsey, and K. K. Bowen Inhibition of Intercellular Adhesion Molecule-1 Protein Expression by Antisense Oligonucleotides Is Neuroprotective After Transient Middle Cerebral Artery Occlusion in Rat Stroke, January 1, 2004; 35(1): 179 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nishiwaki, T. Ueda, S. Ugawa, S. Shimada, and Y. Ogura Upregulation of P-selectin and Intercellular Adhesion Molecule-1 after Retinal Ischemia-Reperfusion Injury Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4931 - 4935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Pfefferkorn and G. A. Rosenberg Closure of the Blood-Brain Barrier by Matrix Metalloproteinase Inhibition Reduces rtPA-Mediated Mortality in Cerebral Ischemia With Delayed Reperfusion Stroke, August 1, 2003; 34(8): 2025 - 2030. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhang, Z. G. Zhang, R. L. Zhang, M. Lu, M. Krams, and M. Chopp Effects of a Selective CD11b/CD18 Antagonist and Recombinant Human Tissue Plasminogen Activator Treatment Alone and in Combination in a Rat Embolic Model of Stroke Stroke, July 1, 2003; 34(7): 1790 - 1795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.J.M. Frijns and L.J. Kappelle Inflammatory Cell Adhesion Molecules in Ischemic Cerebrovascular Disease Stroke, August 1, 2002; 33(8): 2115 - 2122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Toomey, R. E. Valocik, P. F. Koster, M. A. Gabriel, M. McVey, T. K. Hart, E. H. Ohlstein, A. A. Parsons, and F. C. Barone Inhibition of Factor IX(a) Is Protective in a Rat Model of Thromboembolic Stroke Stroke, February 1, 2002; 33(2): 578 - 585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhang, Z. G. Zhang, R. L. Zhang, M. Lu, J. Adams, P. J. Elliott, and M. Chopp Postischemic (6-Hour) Treatment With Recombinant Human Tissue Plasminogen Activator and Proteasome Inhibitor PS-519 Reduces Infarction in a Rat Model of Embolic Focal Cerebral Ischemia Stroke, December 1, 2001; 32(12): 2926 - 2931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Morris, L. Zhang, Z. G. Zhang, M. Lu, K. L. Berens, P. M. Brown, and M. Chopp Extension of the Therapeutic Window for Recombinant Tissue Plasminogen Activator With Argatroban in a Rat Model of Embolic Stroke Stroke, November 1, 2001; 32(11): 2635 - 2640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Popa-Wagner, B. Fischer, D. Platt, H. Schmoll, and C. Kessler Delayed and Blunted Induction of mRNA for Tissue Plasminogen Activator in the Brain of Old Rats Following Pentylenetetrazole-Induced Seizure Activity J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2000; 55(5): 242B - 248. [Abstract] [Full Text]
|
|
|
|
|
|
D. C. Hess, E. Howard, C. Cheng, J. Carroll, W. D. Hill, and C. Y. Hsu Hypertonic Mannitol Loading of NF-{kappa}B Transcription Factor Decoys in Human Brain Microvascular Endothelial Cells Blocks Upregulation of ICAM-1 Editorial Comment Stroke, May 1, 2000; 31(5): 1179 - 1186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ishikawa, E. Sekizuka, S. Sato, N. Yamaguchi, J. Inamasu, H. Bertalanffy, T. Kawase, and C. Iadecola Effects of Moderate Hypothermia on Leukocyte- Endothelium Interaction in the Rat Pial Microvasculature After Transient Middle Cerebral Artery Occlusion • Editorial Comment Stroke, August 1, 1999; 30(8): 1679 - 1686. [Abstract] [Full Text] [PDF]
|
|